Clinical Trial Update: Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating triptorelin to prevent chemotherapy-induced ovarian damage in adolescents and young adults with cancer is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Solid Tumor

Drugs mentioned

• Decapeptyl (triptorelin acetate)

Snippet

Sponsor: Children's Oncology Group | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 3 | Status: RECRUITING